Texas Alzheimer's Research Consortium
The test is the latest of several Alzheimer's biomarker panels developed on Rules-Based Medicine's DiscoveryMAP platform. The company plans to develop a specialized assay for research use by next year with a lab-developed test potentially following shortly thereafter.
Consortium Develops Algorithm from Blood-Based Alzheimer's Biomarkers
Researchers participating in the Texas Alzheimer's Research Consortium have identified protein biomarkers in blood that differ between individuals with and without Alzheimer's disease and incorporated them into an algorithm for detecting Alzheimer's cases.